UC partnering in webinar on treatments for young people at risk for substance use disorders
Event Information (passed)
A free webinar, "Tailoring Conversations and Treatment to Adolescents and Young Adults at Risk for Substance Use Disorder" is being offered Thursday, Aug. 8, 2019, from 1 p.m. to 2 p.m. Designed for health care professionals working with youth and young adults in the fields of nursing, pharmacy, medicine, social work, counseling and teaching, the webinar is co-sponsored by the University of Cincinnati College of Allied Health Sciences and College of Education, Criminal Justice and Human Services.
This session is part of the SBIRT webinar series. SBIRT, which stands for screening, brief intervention and referral to treatment, is a comprehensive, integrated public health approach to the delivery of early intervention and treatment services for persons with substance abuse disorders, as well as those who are at risk of developing those disorders. The webinar series is part of the Adolescent SBIRT project which is a collaboration with the National Opinion Research Center at the University of Chicago. Funding is provided by the Conrad N. Hilton Foundation.
Click here for more information about the webinar and here to register.
Additional Contacts
Related Stories
UC Board of Trustees approves $12 million for building design phase for new welcome gateway
March 13, 2026
The UC Board of Trustees approved $12 million at its Feb. 24 meeting for the design phase of a new Welcome Gateway Building for Uptown campus.
Study: Additional radiation for liver cancer does not increase toxicity
March 10, 2026
New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.
Is uACR the key to cardiovascular and kidney disease prevention?
March 8, 2026
As a precision biomarker, the urinary albumin-to-creatinine ratio (uACR) can guide physicians toward personalized, patient-centered prevention and treatment of both cardiovascular disease (CVD) and chronic kidney disease (CKD), according to new data published in the Journal of Internal Medicine.